Oppenheimer (NYSE:OPY - Get Free Report) released its earnings results on Friday. The financial services provider reported $4.21 EPS for the quarter, Zacks reports. The firm had revenue of $445.10 million for the quarter. Oppenheimer had a return on equity of 16.10% and a net margin of 9.06%.
Oppenheimer Trading Down 7.2%
NYSE:OPY traded down $8.25 during mid-day trading on Friday, reaching $106.23. The company's stock had a trading volume of 155,574 shares, compared to its average volume of 58,786. Oppenheimer has a 12-month low of $59.54 and a 12-month high of $118.77. The firm's fifty day moving average price is $95.11 and its two-hundred day moving average price is $81.36. The stock has a market cap of $1.14 billion, a P/E ratio of 8.15 and a beta of 1.14.
Oppenheimer News Summary
Here are the key news stories impacting Oppenheimer this week:
- Positive Sentiment: Top-line growth — Revenue rose to $445.1 million (year‑over‑year increase reported by the company), demonstrating business momentum despite the profitability miss. PR Newswire: Q1 2026 Earnings
- Positive Sentiment: Institutional interest — Several large funds added shares in Q4 2025 (e.g., Millennium Management, State Street), which suggests some investor confidence in the franchise and could provide support over time. QuiverQuant: Institutional Moves
- Neutral Sentiment: Analyst/activity mentions — Oppenheimer the firm remains active as an analyst/underwriter (coverage notes and industry lists), which is background business but not a direct short‑term driver of OPY’s price. InsiderMonkey: Analyst Activity
- Negative Sentiment: Profitability miss — The firm reported a net loss of $20.6 million, or $(1.93) per share, versus net income a year earlier; that earnings swing is the primary near‑term catalyst for the stock decline. PR Newswire: Q1 2026 Earnings
- Negative Sentiment: Cash flow and liquidity concerns — Third‑party data highlighted large cash used in operations (about $190M) and relatively low cash on hand (~$34.6M), plus rising total liabilities — factors that can worry investors about near‑term financial flexibility. QuiverQuant: Financial Details
- Negative Sentiment: Market signals increasing pressure — An insider sale was reported and short interest has risen materially, which can magnify downward moves on weak results and volume spikes. QuiverQuant: Insider Trade AmericanBankingNews: Short Interest
Analysts Set New Price Targets
OPY has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Oppenheimer from a "buy" rating to a "strong-buy" rating in a research note on Saturday, March 7th. Cantor Fitzgerald cut shares of Oppenheimer to a "buy" rating in a report on Wednesday, January 7th. Finally, Weiss Ratings upgraded shares of Oppenheimer from a "buy (b-)" rating to a "buy (b)" rating in a research note on Tuesday, April 21st. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, Oppenheimer presently has an average rating of "Buy".
View Our Latest Stock Report on OPY
Insider Activity
In other news, insider Dennis P. Mcnamara sold 4,673 shares of Oppenheimer stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $90.67, for a total value of $423,700.91. Following the completion of the sale, the insider directly owned 20,177 shares in the company, valued at $1,829,448.59. The trade was a 18.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 34.86% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Oppenheimer
A number of large investors have recently added to or reduced their stakes in OPY. Millennium Management LLC lifted its holdings in shares of Oppenheimer by 56.6% during the 4th quarter. Millennium Management LLC now owns 114,737 shares of the financial services provider's stock valued at $8,294,000 after buying an additional 41,485 shares during the period. State Street Corp increased its position in Oppenheimer by 109.6% during the fourth quarter. State Street Corp now owns 67,421 shares of the financial services provider's stock valued at $4,941,000 after acquiring an additional 35,250 shares during the last quarter. Marshall Wace LLP bought a new position in Oppenheimer in the second quarter valued at about $2,016,000. Algert Global LLC boosted its position in Oppenheimer by 726.5% in the third quarter. Algert Global LLC now owns 33,779 shares of the financial services provider's stock worth $2,497,000 after purchasing an additional 29,692 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its position in Oppenheimer by 146.4% in the second quarter. JPMorgan Chase & Co. now owns 44,842 shares of the financial services provider's stock worth $2,949,000 after purchasing an additional 26,643 shares during the last quarter. Institutional investors own 32.26% of the company's stock.
Oppenheimer Company Profile
(
Get Free Report)
Oppenheimer & Co Inc is a full-service investment bank and wealth management firm headquartered in New York City. Founded in the mid-20th century, the company provides a broad array of financial services to individual, institutional and corporate clients. Its core competencies include equity and fixed-income research, institutional sales and trading, underwriting and merger-and-acquisition advisory.
In the wealth management segment, Oppenheimer offers tailored investment solutions, comprehensive financial planning and retirement strategies.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oppenheimer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oppenheimer wasn't on the list.
While Oppenheimer currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.